Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: Lessons from a systematic review of recent randomized trials

Critical Reviews in Oncology/Hematology

Volumn 81, Issue 1, 2012, Pages 21-28

  Gerard, Jean Pierre ^a   Rostom, Yousri ^b   Gal, Jocelyn ^a   Benchimol, Daniel ^c   Ortholan, Cécile ^a   Aschele, Carlo ^d   Levi, Jean Michel Hannoun ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c UNIVERSITY HOSPITAL OF NICE   (France)

^d Oncologia Medica B   (Italy)

Author keywords

Conservative treatment; Neoadjuvant treatment; Randomized trial; Rectal cancer; Review; Sphincter saving surgery

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; REVIEW; RISK REDUCTION; SURGICAL TECHNIQUE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANAL CANAL; HUMANS; NEOADJUVANT THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS;

EID: 80053313761     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2011.02.001     Document Type: Review

References (38)

1. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986, 1:1479-1482.
2. Enker W.E., Thaler H.T., Cranor M.L., Polyak T. Total mesorectal excision in the operative treatment of rectal cancer. J Am Coll Surg 1995, 181:335-346.
3. Krouse R.S., Herrinton L.J., Grant M., et al. Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex. J Clin Oncol 2009, 27:4664-4670.
4. Moore H.G., Riedel E., Minsky B.D., et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003, 10(January-February (1)):80-85.
5. Nelson H., Petrelli N., Carlin A., et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001, 93:583-596.
6. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
7. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.
8. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
9. Gérard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625.
10. Crane C.H., Skibber J.M., Birnbaum E.H., et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumour response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003, 57:84-89.
11. Valentini V., Coco C., Cellini N., et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998, 40:1067-1075.
12. Bujko K., Kepka L., Michalski W., Nowacki M.P. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006, 80:4-12.
13. Sebag-Montefiore D., Stephens R.J., Steele R., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373:811-820.
14. Aschele C., Pinto C., Cordio S., et al. Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adjuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol 2009, 27(Suppl. 18). [abstr CRA4008].
15. Gérard J.P., Azria D., Gourgou-Bourgade S., et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer. Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010, 28:1638-1644.
16. Ngan S., Fisher R., Goldstein D., et al. A randomized trial comparing local recurrence rates between short-course and long-course preoperative radiotherapy for clinical T3 rectal cancer: an intergroup trial (TROG, AGITG, CSSANZ RACS). J Clin Oncol 2010, 28(Suppl. 7). [abstr 3509].
17. Gérard A., Buyse M., Nordlinger B., et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988, 208:606-614.
18. James R.D., Haboubi N., Schofield P.F., Mellor M., Salhab N. Prognostic factors in colorectal carcinoma treated by preoperative radiotherapy and immediate surgery. Dis Colon Rectum 1991, 34:546-551.
19. François Y., Nemoz C.J., Baulieux J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999, 17:2396-2402.
20. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72:15-24.
21. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., Michalski W., Bebenek M., Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006, 93:1215-1223.
22. Gerard J.P., Chapet O., Nemoz C., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol 2004, 22:2404-2409.
23. Braendengen M., Tveit K.M., Berglund A., et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008, 26:3687-3694.
24. Påhlman L., Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990, 211:187-195.
25. Swedish rectal cancer trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. NEJM 1997;336:980-987.
26. Folkesson J., Birgisson H., Pahlman L., Cedermark B., Glimelius B., Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005, 23:5644-5650.
27. Roh M.S., Colangelo L.H., O'Connell M.J., et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009, 27:5124-5130.
28. Mohiuddin M., Winter K., Mitchell E., et al. Randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006, 24:650-655.
29. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004, 240:711-717.
30. Habr-Gama A., Perez R.O., Sabbaga J., et al. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 2009, 52:1927-1934.
31. Papillon J. Present status of radiation therapy in the conservative management of rectal cancer. Radiother Oncol 1990, 17:275-283.
32. Gérard J.P., Chapet O., Ramaioli A., Romestaing P. Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone. IJROBP 2002, 54:142-149.
33. Horiot J.C., Roth S.L., Calais G., Nabid A., Bone-Lepinoy M.C., Loiseau D. The Dijon clinical staging system for early rectal carcinomas amenable to intracavitary treatment techniques. Radiother Oncol 1990, 18:329-337.
34. Myerson R.J., Hunt S.R. Conservative alternatives to extirpative surgery for rectal cancer. Clin Oncol 2007, 19:682-686.
35. Cummings B.J. Is there a limit to dose escalation for rectal cancer?. Clin Oncol 2007, 19:730-737.
36. Ortholan C., Francois E., Thomas O., et al. Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum 2006, 49:302-310.
37. Lezoche G., Baldarelli M., Guerrieri M., et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 2008, 22:352-358.
38. Garcia Aguilar J. Pathologic complete response to neoadjuvant chemoradiation of uT2 N0 rectal cancer treated by local excision: results of the ACOSOG Z6041 trial. J Clin Oncol 2010, 28(Suppl. 7). [Abstr 3510].